Informa (LON:INF – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at UBS Group in a report released on Friday, Marketbeat.com reports. They presently have a GBX 1,055 target price on the stock. UBS Group’s target price indicates a potential upside of 8.99% from the stock’s previous close.
INF has been the subject of several other research reports. JPMorgan Chase & Co. assumed coverage on shares of Informa in a research note on Wednesday, September 3rd. They issued an “overweight” rating and a GBX 1,020 target price for the company. Deutsche Bank Aktiengesellschaft increased their target price on Informa from GBX 1,000 to GBX 1,140 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Four equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of GBX 1,036.25.
Get Our Latest Research Report on INF
Informa Trading Down 1.0%
About Informa
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
Read More
- Five stocks we like better than Informa
- Transportation Stocks Investing
- CrowdStrike Partners With CoreWeave But Investors Sell the News
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Amprius Technologies Signals Electrifying Growth in 2026
- How to Effectively Use the MarketBeat Ratings Screener
- Dave Stock: 180% Gain + Q3 Beat = Breakout Setup?
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.
